Evidence map›Paper›PMID 37261588›Full record

ReviewAnnals of biomedical engineering2023

3D and 4D Bioprinting Technologies: A Game Changer for the Biomedical Sector?

Reza Noroozi, Zia Ullah Arif, Hadi Taghvaei, Muhammad Yasir Khalid, Hossein Sahbafar, Amin Hadi, Ali Sadeghianmaryan, Xiongbiao Chen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of biomedical engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Stimuli-responsive hybrid materials for 4DMaterials today. Bio · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. Extrusion bioprinting: meeting the promise of human tissue biofabrication?Progress in biomedical engineering (Bristol, England) · 2025
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Reza NorooziSchool of Mechanical Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran.
Zia Ullah ArifDepartment of Mechanical Engineering, University of Management & Technology, Lahore, Sialkot Campus, Lahore, 51041, Pakistan.
Hadi TaghvaeiSchool of Mechanical Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran.
Muhammad Yasir KhalidDepartment of Aerospace Engineering, Khalifa University of Science and Technology, PO Box: 127788, Abu Dhabi, United Arab Emirates.
Hossein SahbafarSchool of Mechanical Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran.
Amin HadiCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Ali SadeghianmaryanPostdoctoral Researcher Fellow at Department of Biomedical Engineering, University of Memphis, Memphis, TN, USA. sdghnmry@memphis.edu.ORCID http://orcid.org/0000-0002-2825-0189
Xiongbiao ChenDepartment of Mechanical Engineering, College of Engineering, University of Saskatchewan, 57 Campus Dr., Saskatoon, SK, S7N5A9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioprinting is an innovative and emerging technology of additive manufacturing (AM) and has revolutionized the biomedical sector by printing three-dimensional (3D) cell-laden constructs in a precise and controlled manner for numerous clinical applications. This approach uses biomaterials and varying types of cells to print constructs for tissue regeneration, e.g., cardiac, bone, corneal, cartilage, neural, and skin. Furthermore, bioprinting technology helps to develop drug delivery and wound healing systems, bio-actuators, bio-robotics, and bio-sensors. More recently, the development of four-dimensional (4D) bioprinting technology and stimuli-responsive materials has transformed the biomedical sector with numerous innovations and revolutions. This issue also leads to the exponential growth of the bioprinting market, with a value over billions of dollars. The present study reviews the concepts and developments of 3D and 4D bioprinting technologies, surveys the applications of these technologies in the biomedical sector, and discusses their potential research topics for future works. It is also urged that collaborative and valiant efforts from clinicians, engineers, scientists, and regulatory bodies are needed for translating this technology into the biomedical, pharmaceutical, and healthcare systems.

Indexed as

BioprintingTissue EngineeringBiocompatible MaterialsPrinting, Three-DimensionalTechnologyBiocompatible Materials3D bioprinting4D bioprintingAdditive manufacturingBiomedical applicationsTissue engineering

Identifiers

PMID37261588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.